← Eichor · All briefs

NCT03226119 — HTLV-I Infections trial site landscape

Public-registry site landscape for NCT03226119, a HTLV-I Infections study sponsored by MP Biomedicals, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT03226119 (registry record)
SponsorMP Biomedicals, LLC
Condition(s)HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic Virus 1; Human T-lymphotropic Virus 2
PhasePHASE4
Listed sites3
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03226119 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.